Networks
Clinical Studies (6)
- Aguareles : Study aims to investigate the effect of compassionate use of plitidepsin as an antiviral therapy in immunocompromised COVID-19 patients with underlying haematological malignancies or solid tumors, particularly those who have undergone anti-CD20 therapies
- Caso : Study aims to evaluate the clinical outcomes of immunocompromised patients treated with nirmatrelvir/ritonavir and to assess the occurrence of drug-to-drug interactions and treatment-emergent adverse events in this population
- Vicente-Valor : Study aims to evaluate the effectiveness and safety of remdesivir and SARS-CoV-2 monoclonal antibodies in preventing COVID-19 progression in patients with hematological malignancies and mild-to-moderate disease in real clinical practice
- Tarín-Vicente : Study aims to comprehensively evaluate the epidemiology, clinical features, and virological features of patients diagnosed with mpox at three large hospitals in Spain
- García-Piqueras : Study aims to characterise patients, their demographics and clinical presentation, presenting to the Dermatology emergency room with a mpox infection in a tertiary hospital in Madrid, Spain
- E-APLICOV-PC : Study aims to evaluate the impact of plitidepsin treatment on reducing viral load and accelerating patient recovery following SARS-CoV-2 infection. To assess whether this treatment could have a relevant impact on the emergence of long-term sequelae resulting from the infection
External Links
Other information
If you would like to contact the site, please email: ccb@ateneo.univr.it
The data is updated up to